Triamide-substituted heterobicyclic compounds
US7393958B2 · kind B2 · utility
1Cited by
9References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 30, 2006 |
| Grant date | Jul 1, 2008 |
| Priority date | — |
| Expiry date | Oct 30, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to MTP/Apo-B secretion inhibitors of Formula (I)wherein R1-R7, X1, m and n are as defined in the specification, as well as pharmaceutical compositions comprising the compounds, and methods of use of the compounds and compositions. The compounds of the invention are useful in treating obesity and associated diseases, conditions or disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.